Sun Pharma Q3 Preview: Consolidated PAT to gain 10% YoY while revenue to rise 11% Dayanand Saini | January 31, 2022 | Stocks News | No Comments Net sales for the quarter likely to rise 11.5 percent year-on-year growth to Rs 9853 crore for the December quarter Related Posts HUL Q4 PAT seen up 31.9% YoY to Rs. 2,002.8 cr: ICICI Direct No Comments | Apr 14, 2021 JEE Main Result 2021: NTA may announce 4th session results today No Comments | Sep 11, 2021 Exide Industries reports Rs 31.8 crore profit in Q1FY22 No Comments | Aug 1, 2021 IDFC Bank Q3 Net Profit to Rs. 135.6 cr: ICICI Direct No Comments | Jan 21, 2021 About The Author Dayanand Saini